Endo Pharmaceuticals Holdings Inc. (ENDP) reported third-quarter net income of $49 million compared to $66 million last year. Reported earnings per share were $0.42 compared to $0.55 last year.
Adjusted net income was $74 million compared to $79 million prior year. Adjusted earnings per share were $0.63 compared to $0.66 last year.
On average, 23 analysts polled by Thomson Reuters expected the company to report profit of $0.65 per share for the quarter. Analysts' estimates typically exclude special items.
Total revenues increased to $361 million from $317 million last year. Analysts expected revenue of $365.33 million for the quarter.
The company raised guidance for 2009 annual total revenues and adjusted earnings per share.
The company now estimates total revenues to be between $1.440 billion-$1.465 billion.
The company now estimates reported earnings per share to be between $1.41 and $1.47.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.